SCHEMBL30784114

SCHEMBL30784114

Cn1c(N2CCOCC2)nc2c(Br)cc(F)cc2c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.42
▸ DRD2 P14416 2/20 0.41
▸ DRD4 P21917 2/20 0.41
▸ DRD3 P35462 2/20 0.41
▸ CYP1A2 P05177 2/20 0.40
▸ DPP4 P27487 3/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ STAT6 P42226 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ CCNC P24863 1/20 0.38
▸ CDK8 P49336 1/20 0.38
▸ TSHR P16473 2/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30783708 0.87 HTT (0.41) HTTDRD2DRD4DRD3CYP1A2
SCHEMBL30784241 0.86 HTT (0.43) HTTDRD2DRD4DRD3CYP1A2
SCHEMBL30784051 0.86 HTT (0.43) HTTDRD2DRD4DRD3CYP1A2
SCHEMBL30784502 0.85 SMN1; SMN2 (0.43) HTTDRD2DRD4DRD3CYP1A2
SCHEMBL30784290 0.85 HTT (0.40) HTTDRD2DRD4DRD3DPP4
SCHEMBL30784287 0.85 CYP1A2 (0.43) CYP1A2KMT2ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL25356627 0.84 PTPN11 (0.39) DRD2DRD4DRD3AKT1PTPN11
SCHEMBL30564445 0.84 AKT1 (0.44) DRD2DRD4DRD3ALDH1A1AKT1
SCHEMBL30784281 0.84 DPP4 (0.45) HTTDRD2DRD4DRD3CYP1A2
SCHEMBL30783853 0.84 HTT (0.39) HTTDRD2DRD4DRD3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback